Home Authors Posts by staff

staff

66 POSTS 0 COMMENTS

Takeda disinvests in Chinese’s Techpool

A new veterinary R&D center in China for Boehringer Ingelheim

The final closing of the Monsanto’s acquisition is nearer

Eli Lilly invests on Aurora kinase inhibitors

The PGT Healthcare partnership at an end

AstraZeneca licensed rights for Seroquel

Human-centered design to improve management of cancer symptoms

A research accelerator for AbbVie

Gsk to transfer its portfolio of rare disease gene therapies

Subcutaneous therapy for chronic inflammatory demyelinating polyneuropathy

1...567Page 6 of 7

Newsstand

  • Supplemento to n.9 - October 2024 NCF International n.3 - 2024
  • NCF International n.2 - 2024
  • Supplemento to n.1 - January 2024 NCF International n.1 - 2024
Newsstand
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151